Share

Pharmaceutical Market Access in Emerging Markets

2016-10-20 Business & Economics
Download Pharmaceutical Market Access in Emerging Markets PDF Online Free

Author :
Release : 2016-10-20
Genre : Business & Economics
Kind : eBook
Book Rating : 64X/5 ( reviews)

GET EBOOK


Book Synopsis Pharmaceutical Market Access in Emerging Markets by : Güvenç Koçkaya

Download or read book Pharmaceutical Market Access in Emerging Markets written by Güvenç Koçkaya. This book was released on 2016-10-20. Available in PDF, EPUB and Kindle. Book excerpt: The definition of Market Access was first reported by the World Trade Organization as “to open markets for trade and improve transparency, reciprocity, and non-discrimination in international trade”. Pharmaceutical Market Access is different and it could be defined as achieving the optimal price for a product or service and/or the maximum reimbursement for the approved target population with no restrictions on funding for the medical technology. By the way, Market Access is not only the market authorization, but it also includes overlapping activities like pricing, health technology assessment, formulary, and reimbursement. Market Access is one of the most important activities for pharmaceutical companies and emerging countries represent an important opportunity for launching new products. It was reported that the Compounded Average Growth Rate (CAGR) was 6.0% in the period 2011-2017, and expected sales exceeding 1.1 trillion USD by 2017 for emerging countries. Furthermore, CAGR 2008-2012 for recently launched pharmaceuticals were 9.8% for emerging countries and 1.5% for the top 8 developed countries. The Market Access processes in the most important emerging countries in the selected regions are defined in this book with the aim to help local experts, local government officers, headquarter managements, and everyone who want to learn more about healthcare system and health policies pathways of Market Access, mapping and structure of decision makers, challenges and catalyzers for Market Access in the emerging countries.

Pharmaceutical Market Access in Developed Markets

2018-01-22 Medical
Download Pharmaceutical Market Access in Developed Markets PDF Online Free

Author :
Release : 2018-01-22
Genre : Medical
Kind : eBook
Book Rating : 747/5 ( reviews)

GET EBOOK


Book Synopsis Pharmaceutical Market Access in Developed Markets by : Güvenç Koçkaya

Download or read book Pharmaceutical Market Access in Developed Markets written by Güvenç Koçkaya. This book was released on 2018-01-22. Available in PDF, EPUB and Kindle. Book excerpt: Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization. It covers a group of activities intended to provide access to the appropriate medicine for the appropriate group of patients at the appropriate price (in most countries). Market Access may also be seen as activities that support the management of potential barriers, such as non-optimal price and reimbursement levels, the restriction of the scope of prescribing for the drug or complicated prescription writing or funding procedures. Since there are cultural differences among countries, any Market Access strategy needs to be culturally sensitive. Pharmaceutical Market Access in emerging markets has been extensively discussed in our previous book, published in 2016. The present book focuses on developed markets with the goal of helping students, academics, industry personnel, government workers, and decision makers understand the environment in developed markets.

Introduction to Market Access for Pharmaceuticals

2017-01-12 Medical
Download Introduction to Market Access for Pharmaceuticals PDF Online Free

Author :
Release : 2017-01-12
Genre : Medical
Kind : eBook
Book Rating : 584/5 ( reviews)

GET EBOOK


Book Synopsis Introduction to Market Access for Pharmaceuticals by : Mondher Toumi

Download or read book Introduction to Market Access for Pharmaceuticals written by Mondher Toumi. This book was released on 2017-01-12. Available in PDF, EPUB and Kindle. Book excerpt: Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers’ needs, the drug will fail to reach its intended market value. Introduction to Market Access for Pharmaceuticals is based on an accredited course in this area, taken from the European Market Access University Diploma (EMAUD), and is affiliated with Aix Marseille University. Key Features: The first guide to market access for pharmaceuticals based on tested teaching materials Addresses both pharmaceutical and vaccine products Includes case studies and scenarios Covers market access consdierations for Western Europe, the USA, Japan and China Explains the impact the changing healthcare market will have on your product

Frontiers in Market Access

2021-05-31
Download Frontiers in Market Access PDF Online Free

Author :
Release : 2021-05-31
Genre :
Kind : eBook
Book Rating : 328/5 ( reviews)

GET EBOOK


Book Synopsis Frontiers in Market Access by : Kasem Akhras

Download or read book Frontiers in Market Access written by Kasem Akhras. This book was released on 2021-05-31. Available in PDF, EPUB and Kindle. Book excerpt:

Equitable Access to High-Cost Pharmaceuticals

2018-02-27 Medical
Download Equitable Access to High-Cost Pharmaceuticals PDF Online Free

Author :
Release : 2018-02-27
Genre : Medical
Kind : eBook
Book Rating : 624/5 ( reviews)

GET EBOOK


Book Synopsis Equitable Access to High-Cost Pharmaceuticals by : Zaheer-Ud-Din Babar

Download or read book Equitable Access to High-Cost Pharmaceuticals written by Zaheer-Ud-Din Babar. This book was released on 2018-02-27. Available in PDF, EPUB and Kindle. Book excerpt: Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. - Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs - Incorporates existing guidelines and recommendations by international organizations - Compares and contrasts how different countries fund and police high-cost drug access - Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing - Reviews novel pharmaceuticals of current research interest

You may also like...